Published • loading... • Updated
Novartis announces plans to build flagship manufacturing hub in North Carolina
Novartis will create over 700 jobs by 2030 and build more than 700,000 sq ft of production space for biologics, sterile packaging, and solid dosage medicines.
- On Wednesday, November 19, 2025, Novartis, the Switzerland-based pharmaceutical company, said it will invest $771 million to build a manufacturing hub creating 700 jobs in Durham and Wake counties.
- Novartis plans to build two sites in Durham and Morrisville, North Carolina, with three new facilities and one expanded facility totaling more than 700,000 square feet.
- The hub is slated to open as early as 2027 and combines new construction with renovation across three sites; average pay is $111,161, exceeding Durham County's $97,531 and Wake County's $76,643.
- The hub will allow teams to operate end-to-end manufacturing from active ingredients to final packaging, part of a $23 billion U.S. expansion pledge amid tariff uncertainty, with a Job Development Investment Grant that could yield nearly $7.56 million over 12 years.
- Novartis is also boosting U.S. R&D and production with an San Diego R&D hub; expansions in Carlsbad, Millburn, Indianapolis; and two new sites in Florida and Texas for radioligand therapies.
Insights by Ground AI
18 Articles
18 Articles
Novartis announces plans to build flagship manufacturing hub in North Carolina
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced…
Coverage Details
Total News Sources18
Leaning Left2Leaning Right2Center2Last UpdatedBias Distribution34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium









